ImageneBio Inc. Company Profile
NASDAQ: IMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
4.48-0.13 (-2.82%)
Market open · Delayed 15 min · as of Oct 8, 10:35 AM ET
ImageneBio at a glance
ImageneBio Inc. (NASDAQ: IMA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $52.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001835579, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- ImageneBio Inc.
- Ticker
- NASDAQ: IMA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $52.22M
- SEC CIK
- 0001835579
Companies similar to ImageneBio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EXOZeXoZymes Inc. | 5.60 | +1.08% | $52.11M | vs IMA |
| BKHABlack Hawk Acquisition Corporation Class A | 12.50 | -3.85% | $51.92M | vs IMA |
| CRBUCaribou Biosciences Inc. | 0.4991 | -19.16% | $53.51M | vs IMA |
| INMBINmune Bio Inc. | 1.83 | -1.61% | $50.79M | vs IMA |
| LONALeonaBio Inc. | 5.76 | -1.20% | $54.27M | vs IMA |
| INKTMiNK Therapeutics Inc. | 11.35 | -0.62% | $57.91M | vs IMA |
| TILInstil Bio Inc. | 6.83 | -0.29% | $46.32M | vs IMA |
| ELOXEloxx Pharmaceuticals Inc. | 14.72 | -1.08% | $59.42M | vs IMA |